Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2008

View Archived Issues

Nur77-derived peptide acts as converter of Bcl-2 receptor inducing apoptosis of cancer cells

Vical receives milestone payment from Merck & Co. for cancer vaccine candidate trial

Less gastrointestinal mucosal damage seen with aspirin-omeprazole compared to aspirin alone

Varespladib shows antiatherosclerotic potential in PLASMA-II trial

Trial suggests metformin chewing gum is bioequivalent to tablets

MonoSol Rx and Strativa complete bioequivalence studies for ondansetron thin film NDA

Inhibition of nigrostriatal-thalamic pathway by Trap-101 beneficial in model of PD

Neuroprotective effects and improved motor performance with metal-chelating agent in PD

Gene therapy can restore arylsulfatase A expression, possibly treat metachromatic leukodystrophy

Adeona and NNRI sign research collaboration for animal studies of Flupirtine in RP

INI treats first patient in phase I/II clinical trial of CellMed's CellBeads for stroke

Kringle initiates phase II clinical trial in Norway of ChronSeal for venous leg ulcers

OncoGenex reports positive results from phase II clinical trial of OGX-011 in prostate cancer

FDA accepts for filing Advanced Life Sciences' NDA for cethromycin in CAP

Cell Genesys and Takeda suspend development of GVAX, terminate collaboration

Pozen reports positive top-line phase III results for PN-400

New glucokinase activators disclosed in recent Takeda and Dainippon Sumitomo Pharma patents

Yakult initiates clinical study of Campto for pancreatic cancer

Novel anti-HCV agents patented by Schering-Plough

Recent Boehringer Ingelheim and GSK patents disclose new therapeutic agents for obesity

Alkermes initiates phase I ALKS-33 trial in healthy volunteers

Cerus receives expanded label claim for Intercept Blood System

MedImmune advances asthma program with phase II MEDI-563 trial

Oncoscience withdraws Theraloc (nimotuzumab) marketing authorization application

VentiRx commences phase I VTX-2337 trial in cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...